datadeal

Health Trust NFT: Patients Take Control After 23andMe Data Deal

Health Trust NFT: Patients Take Control After 23andMe Data Deal

The recent deal involving Regeneron and 23andMe, where genetic data is shared for research purposes, has reignited the debate surrounding patient data ownership and privacy. New innovative solutions are popping up everywhere to help put power back in the hands of people. These innovations allow consumers to have more command...

Further Reading